Menu
Back to Journals » OncoTargets and Therapy » Volume 14
Case report
A Remarkable and Durable Response to Sintilimab and Anlotinib in the First-Line Treatment of an Anaplastic Thyroid Carcinoma without Targetable Genomic Alterations: A Case Report
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,907 | Dovepress* | 4,430+ | 675 | 5,105 | |
| PubMed Central* | 477 | 218 | 695 | ||
| Totals | 4,907 | 893 | 5,800 | ||
| *Since 20 April 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar